Abstract
This article focuses on the ability of dendritic molecules to interact with nucleic acids and hence deliver them into cells. Dendritic molecules have branched structures which are made by an iterative, layer-by-layer synthesis. The control applied in their synthesis means that dendrimers are well-defined nanoscale molecular species - ideal for interacting with nanoscale bio-targets such as DNA/RNA. Binding and delivery of genetic material into cells in vivo holds out the prospect of gene therapy, and we will consider the potential advantages of dendritic vectors in this field of nanomedicine. As this article illustrates, the synthetic versatility of dendritic molecules has enabled the synthesis of a wide array of DNA binders and delivery vehicles, with different advantages. This versatility forms the basis for optimism that the dendritic approach may well yield active, highly targeted delivery vectors, suitable for in vivo application in gene therapy
Keywords: Dendrimers and dendrons, DNA, gene therapy, siRNA, vectors
Current Topics in Medicinal Chemistry
Title: Dendrimers and the Double Helix - From DNA Binding Towards Gene Therapy
Volume: 8 Issue: 14
Author(s): David K. Smith
Affiliation:
Keywords: Dendrimers and dendrons, DNA, gene therapy, siRNA, vectors
Abstract: This article focuses on the ability of dendritic molecules to interact with nucleic acids and hence deliver them into cells. Dendritic molecules have branched structures which are made by an iterative, layer-by-layer synthesis. The control applied in their synthesis means that dendrimers are well-defined nanoscale molecular species - ideal for interacting with nanoscale bio-targets such as DNA/RNA. Binding and delivery of genetic material into cells in vivo holds out the prospect of gene therapy, and we will consider the potential advantages of dendritic vectors in this field of nanomedicine. As this article illustrates, the synthetic versatility of dendritic molecules has enabled the synthesis of a wide array of DNA binders and delivery vehicles, with different advantages. This versatility forms the basis for optimism that the dendritic approach may well yield active, highly targeted delivery vectors, suitable for in vivo application in gene therapy
Export Options
About this article
Cite this article as:
Smith K. David, Dendrimers and the Double Helix - From DNA Binding Towards Gene Therapy, Current Topics in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/156802608785849030
DOI https://dx.doi.org/10.2174/156802608785849030 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypersensitivity Reactions to Quinolones
Current Pharmaceutical Design The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
Mini-Reviews in Medicinal Chemistry Polyethylene Glycol Acts as a Mechanistic Stabilizer of L-asparaginase: A Computational Probing
Medicinal Chemistry The Concept of Dysregulated Signal Transduction and Gene Expression in the Pathophysiology of Mood Disorders
Current Psychiatry Reviews Dendritic Cells and the Promise of Therapeutic Vaccines for Human Immunodeficiency Virus (HIV)-1
Current HIV Research Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Discriminating Ramos and Jurkat Cells with Image Textures from Diffraction Imaging Flow Cytometry Based on a Support Vector Machine
Current Bioinformatics Pyrazolines: A Biological Review
Mini-Reviews in Medicinal Chemistry Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent
Anti-Cancer Agents in Medicinal Chemistry Exosomes: A Promising Factor Involved in Cancer Hypoxic Microenvironments
Current Medicinal Chemistry Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design 5q- syndrome
Current Pharmaceutical Design New Anticancer Drugs from Marine Cyanobacteria
Current Drug Targets The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Aerosol Delivery in the Treatment of Lung Cancer
Current Cancer Drug Targets FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism Crosstalk Between DNA and Histones: Tet’s New Role in Embryonic Stem Cells
Current Genomics